Advertisement

Topics

Cowen $EDIT dinner senior Editas mGT. EDIT anticipates filing EDIT-101's IND in Oct,with a proof-of-concept Ph. I/II to start shortly after. EDIT's goal have its leading CRISPR gene editing platform deliver 2 programs to late-stage clinical trials,&3 more

20:05 EDT 14 Sep 2018 | tgtxdough

Cowen dinner senior Editas mGT. EDIT anticipates filing EDIT-101's IND in Oct,with a proof-of-concept Ph. I/II to start shortly after. EDIT's goal have its leading CRISPR gene editing platform deliver 2 programs to late-stage clinical trials,&3 more to early studies,by 2022

Original Article: Cowen $EDIT dinner senior Editas mGT. EDIT anticipates filing EDIT-101's IND in Oct,with a proof-of-concept Ph. I/II to start shortly after. EDIT's goal have its leading CRISPR gene editing platform deliver 2 programs to late-stage clinical trials,&3 more

NEXT ARTICLE

More From BioPortfolio on "Cowen $EDIT dinner senior Editas mGT. EDIT anticipates filing EDIT-101's IND in Oct,with a proof-of-concept Ph. I/II to start shortly after. EDIT's goal have its leading CRISPR gene editing platform deliver 2 programs to late-stage clinical trials,&3 more"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...